Pricing Log in Create free account

Hemab Therapeutics Holdings, Inc. (COAG) vs Lakefront Biotherapeutics - Sponsored ADR (LKFT)

Hemab Therapeutics Holdings, Inc. and Lakefront Biotherapeutics - Sponsored ADR are both Biotechnology companies. Hemab Therapeutics Holdings, Inc. and Lakefront Biotherapeutics - Sponsored ADR are of similar size ($2.2B and $2.1B). Hemab Therapeutics Holdings, Inc. has the higher net margin (0.00% vs −6.81%) and the higher return on invested capital (0.00% vs 0.00%). Across the 8 metrics below, Hemab Therapeutics Holdings, Inc. leads on 5 and Lakefront Biotherapeutics - Sponsored ADR on 3.

Valuation

Metric COAG LKFT Biotechnology median
P/E n/m n/m 10.60
P/S n/m 7.79 9.40
P/B 3.22 0.58 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.96 0.66
EV/Sales n/m (1.42) 9.02
Earnings yield (110.83%) (0.85%) (32.88%)
Free cash flow yield (4.97%) (27.14%) (23.13%)

Profitability

Metric COAG LKFT Biotechnology median
Gross margin — 89.75% 68.51%
Operating margin 0.00% (90.11%) 0.00%
Net margin 0.00% (6.81%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 0.00% (51.96%)
Return on assets (31.79%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric COAG LKFT Biotechnology median
Revenue growth (TTM) — (52.22%) 6.76%
EPS growth (last fiscal year) — 355.37% 29.88%
Revenue growth, 5-year CAGR — 15.75% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric COAG LKFT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 35.85 32.84 4.97
Net debt to EBITDA — (8.53) 1.01

Dividend

Metric COAG LKFT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric COAG LKFT Biotechnology median
Market cap 2.13b 2.20b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack